While breast cancer is rare in men, it does happen. Any cell in your body can become cancerous. So even though men have a very small amount of breast tissue, cancer can develop there. The American Author: R. Morgan Griffin. WebMD explains breast cancer in men, including risk factors and how it's diagnosed and treated. Other things that raise the odds for male breast cancer include: the same treatments that.
Male breast cancer is a disease in which malignant (cancer) cells form in the tissues of the breast. Breast cancer may occur in men. Breast cancer may occur in men at any age, but it usually occurs in men between 60 and 70 years of age. Male breast cancer makes up less than 1% of all cases of breast. Most men who have been diagnosed with breast cancer will undergo some form of treatment for the disease. The most favorable course of treatment will depend on a number of factors, including the size and location of the breast tumor, the stage of the cancer, and results of other laboratory tests.
Male breast cancer is a disease in which malignant (cancer) cells form in the tissues of the breast. Breast cancer may occur in men. Men at any age may develop breast cancer, but it is usually detected (found) in men between 60 and 70 years of age. Male breast cancer makes up less than 1% of . Feb 21, · Male breast cancer is staged (reflecting the extent of tumor spread) identically to breast cancer in women. Surgery is the most common initial treatment for male breast cancer. Depending on the situation, chemotherapy, radiation therapy, and hormonal therapy .
Male breast cancer treatment may include surgery with or without radiation therapy, chemotherapy, endocrine therapy, and/or HER2-directed therapy. Get detailed information about the diagnosis and treatment of newly diagnosed and recurrent male breast cancer in this summary for clinicians. Most of the information about treating male breast cancer comes from doctors' experience with treating female breast cancer. Because so few men have breast cancer, it is hard for doctors to study the treatment of male breast cancer patients separately in clinical trials.